Dr Webb is Consultant in Intensive Care Medicine, Deputy Medical Director and Responsible Officer at Royal Papworth Hospital Cambridge. His clinical, education and research interests lie in cardiothoracic intensive care, severe acute respiratory failure, advanced heart failure and cardiogenic shock, clinical adult and quality improvement.
He is also member of the Medical Practitioners Tribunal Service (MPTS) Committee, Chair of the UK MEDUSA Injectable Medicines Guide Advisory Board and member of the Advisory Committee for Clinical Impact Awards (ACCIA) Committee.
His previous positions include Chair of the UK Critical Care Leadership Forum (CCLF), President of the UK Intensive Care Society (ICS), Clinical Lead of the Eastern Academic Health Science Network (EAHSN) Patient Safety Collaborative and Member of NHS East of England Clinical Senate Council.
- Intensive care
- Cardiothoracic intensive care
- Severe acute respiratory failure
- Advanced heart failure and Cardiogenic shock
- Clinical audit and Quality improvement
- Cardiothoracic intensive care
- Severe acute respiratory failure
- Advanced heart failure and Cardiogenic shock
- Clinical audit and Quality improvement
- Faculty of Forensic & Legal Medicine Diploma in Legal Medicine (DLM) UK - 2014
- Foundation Fellow of the Faculty of Intensive Care Medicine (FFICM) UK - 2011
- Royal College of Anaesthetists (RCA) & Inter-collegiate Board for Training in Intensive Care Medicine (IBTICM) UK – Dual Speciality Certificate of Completion of Training (CCT) in Anaesthesia & Intensive Care Medicine – 2008
- European Society of Intensive Care Medicine Diploma in Intensive Care (EDIC) – 2007
- Fellowship of the Royal College of Anaesthetists (FRCA) UK – 2003
- Bachelor of Medicine, Bachelor of Surgery and Bachelor of Obstetrics (MB BCh BAO) – Queen’s University Belfast UK – 1999
- Member of the Medical Practitioners Tribunal Service (MPTS) Committee - from Oct 2024
- Member of the Advisory Committee for Clinical Impact Awards (ACCIA) Committee - from Feb 2020
- Chair of the MEDUSA Injectable Medicines Guide Advisory Board - from Jun 2019
